Clinical Trials Browser

Phase EARLY_PHASE1 × Triple Negative Breast Neoplasms × Interferon alpha-2 × Clear all

NCT03599453 2023-07-18

Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer

Phase EARLY_PHASE1 Completed

Triple Negative Breast Neoplasms